Literature DB >> 6347441

Hyperthyroidism due to a TSH secreting pituitary adenoma: case report, treatment and evidence for adenoma TSH by morphological and cell culture studies.

K Mashiter, S Van Noorden, R Fahlbusch, H Fill, K Skrabal.   

Abstract

A 36-year-old woman with recurrent hyperthyroidism, inappropriately elevated serum TSH, and an 8 mm pituitary microadenoma is described. Transsphenoidal adenomectomy rapidly reduced serum TSH to normal and restored the euthyroid state with retention of other anterior pituitary functions. Tissue removed at operation was examined by light and electron microscopy and cell culture. The tissue was neoplastic, composed of irregular often elongated cells which immunostrained positively only with antisera to beta-TSH. The cells contained small granules (100-170 nm) usually along the cell membrane. In cell culture TSH alone was secreted and the rate of secretion declined with time. We conclude that the patient had a TSH secreting microadenoma as a cause of her hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347441     DOI: 10.1111/j.1365-2265.1983.tb02877.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Clinical hyperthyroidism due to non-neoplastic inappropriate thyrotrophin secretion.

Authors:  A W Chan; I A MacFarlane; C van Heyningen; P M Foy
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

2.  In vitro studies on TSH secretion and adenylate cyclase activity in a human TSH-secreting pituitary adenoma. Effects of somatostatin and dopamine.

Authors:  A Spada; M Bassetti; E Martino; G Giannattasio; P Beck-Peccoz; A Sartorio; L Vallar; L Baschieri; A Pinchera; G Faglia
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

3.  Role of cell and explant culture in the diagnosis and characterization of human pituitary tumours.

Authors:  E F Adams; K Mashiter
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.